Table of Content

1 Report Overview
1.1 Vector-Based RNAi Definition
1.2 Market by Type
1.2.1 Global Vector-Based RNAi Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 siRNA Design
1.2.3 siRNA Vectors
1.2.4 Custom siRNA Construction
1.3 Market Segment by Application
1.3.1 Global Vector-Based RNAi Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Hospitals
1.3.3 Speciality Clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Vector-Based RNAi Sales
2.1 Global Vector-Based RNAi Revenue Estimates and Forecasts 2018-2034
2.2 Global Vector-Based RNAi Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Vector-Based RNAi Revenue by Region
2.3.1 Global Vector-Based RNAi Revenue by Region (2018-2024)
2.3.2 Global Vector-Based RNAi Revenue by Region (2024-2034)
2.4 Global Vector-Based RNAi Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Vector-Based RNAi Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Vector-Based RNAi Sales Quantity by Region
2.6.1 Global Vector-Based RNAi Sales Quantity by Region (2018-2024)
2.6.2 Global Vector-Based RNAi Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Vector-Based RNAi Sales Quantity by Manufacturers
3.1.1 Global Vector-Based RNAi Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Vector-Based RNAi Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Vector-Based RNAi Sales in 2022
3.2 Global Vector-Based RNAi Revenue by Manufacturers
3.2.1 Global Vector-Based RNAi Revenue by Manufacturers (2018-2024)
3.2.2 Global Vector-Based RNAi Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Vector-Based RNAi Revenue in 2022
3.3 Global Vector-Based RNAi Sales Price by Manufacturers
3.4 Global Key Players of Vector-Based RNAi, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Vector-Based RNAi Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Vector-Based RNAi, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Vector-Based RNAi, Product Offered and Application
3.8 Global Key Manufacturers of Vector-Based RNAi, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Vector-Based RNAi Sales Quantity by Type
4.1.1 Global Vector-Based RNAi Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Vector-Based RNAi Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Vector-Based RNAi Sales Quantity Market Share by Type (2018-2034)
4.2 Global Vector-Based RNAi Revenue by Type
4.2.1 Global Vector-Based RNAi Historical Revenue by Type (2018-2024)
4.2.2 Global Vector-Based RNAi Forecasted Revenue by Type (2024-2034)
4.2.3 Global Vector-Based RNAi Revenue Market Share by Type (2018-2034)
4.3 Global Vector-Based RNAi Price by Type
4.3.1 Global Vector-Based RNAi Price by Type (2018-2024)
4.3.2 Global Vector-Based RNAi Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Vector-Based RNAi Sales Quantity by Application
5.1.1 Global Vector-Based RNAi Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Vector-Based RNAi Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Vector-Based RNAi Sales Quantity Market Share by Application (2018-2034)
5.2 Global Vector-Based RNAi Revenue by Application
5.2.1 Global Vector-Based RNAi Historical Revenue by Application (2018-2024)
5.2.2 Global Vector-Based RNAi Forecasted Revenue by Application (2024-2034)
5.2.3 Global Vector-Based RNAi Revenue Market Share by Application (2018-2034)
5.3 Global Vector-Based RNAi Price by Application
5.3.1 Global Vector-Based RNAi Price by Application (2018-2024)
5.3.2 Global Vector-Based RNAi Price Forecast by Application (2024-2034)
6 North America
6.1 North America Vector-Based RNAi Sales by Company
6.1.1 North America Vector-Based RNAi Revenue by Company (2018-2024)
6.1.2 North America Vector-Based RNAi Sales Quantity by Company (2018-2024)
6.2 North America Vector-Based RNAi Market Size by Type
6.2.1 North America Vector-Based RNAi Sales Quantity by Type (2018-2034)
6.2.2 North America Vector-Based RNAi Revenue by Type (2018-2034)
6.3 North America Vector-Based RNAi Market Size by Application
6.3.1 North America Vector-Based RNAi Sales Quantity by Application (2018-2034)
6.3.2 North America Vector-Based RNAi Revenue by Application (2018-2034)
6.4 North America Vector-Based RNAi Market Size by Country
6.4.1 North America Vector-Based RNAi Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Vector-Based RNAi Revenue by Country (2018-2034)
6.4.3 North America Vector-Based RNAi Sales Quantity by Country (2018-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Vector-Based RNAi Sales by Company
7.1.1 Europe Vector-Based RNAi Sales Quantity by Company (2018-2024)
7.1.2 Europe Vector-Based RNAi Revenue by Company (2018-2024)
7.2 Europe Vector-Based RNAi Market Size by Type
7.2.1 Europe Vector-Based RNAi Sales Quantity by Type (2018-2034)
7.2.2 Europe Vector-Based RNAi Revenue by Type (2018-2034)
7.3 Europe Vector-Based RNAi Market Size by Application
7.3.1 Europe Vector-Based RNAi Sales Quantity by Application (2018-2034)
7.3.2 Europe Vector-Based RNAi Revenue by Application (2018-2034)
7.4 Europe Vector-Based RNAi Market Size by Country
7.4.1 Europe Vector-Based RNAi Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Vector-Based RNAi Revenue by Country (2018-2034)
7.4.3 Europe Vector-Based RNAi Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Vector-Based RNAi Sales by Company
8.1.1 China Vector-Based RNAi Sales Quantity by Company (2018-2024)
8.1.2 China Vector-Based RNAi Revenue by Company (2018-2024)
8.2 China Vector-Based RNAi Market Size by Type
8.2.1 China Vector-Based RNAi Sales Quantity by Type (2018-2034)
8.2.2 China Vector-Based RNAi Revenue by Type (2018-2034)
8.3 China Vector-Based RNAi Market Size by Application
8.3.1 China Vector-Based RNAi Sales Quantity by Application (2018-2034)
8.3.2 China Vector-Based RNAi Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Vector-Based RNAi Sales by Company
9.1.1 APAC Vector-Based RNAi Sales Quantity by Company (2018-2024)
9.1.2 APAC Vector-Based RNAi Revenue by Company (2018-2024)
9.2 APAC Vector-Based RNAi Market Size by Type
9.2.1 APAC Vector-Based RNAi Sales Quantity by Type (2018-2034)
9.2.2 APAC Vector-Based RNAi Revenue by Type (2018-2034)
9.3 APAC Vector-Based RNAi Market Size by Application
9.3.1 APAC Vector-Based RNAi Sales Quantity by Application (2018-2034)
9.3.2 APAC Vector-Based RNAi Revenue by Application (2018-2034)
9.4 APAC Vector-Based RNAi Market Size by Region
9.4.1 APAC Vector-Based RNAi Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Vector-Based RNAi Revenue by Region (2018-2034)
9.4.3 APAC Vector-Based RNAi Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Vector-Based RNAi Sales by Company
10.1.1 Middle East, Africa and Latin America Vector-Based RNAi Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Vector-Based RNAi Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Vector-Based RNAi Market Size by Type
10.2.1 Middle East, Africa and Latin America Vector-Based RNAi Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Vector-Based RNAi Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Vector-Based RNAi Market Size by Application
10.3.1 Middle East, Africa and Latin America Vector-Based RNAi Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Vector-Based RNAi Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Vector-Based RNAi Market Size by Country
10.4.1 Middle East, Africa and Latin America Vector-Based RNAi Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Vector-Based RNAi Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Vector-Based RNAi Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Merck & Co.
11.1.1 Merck & Co. Company Information
11.1.2 Merck & Co. Overview
11.1.3 Merck & Co. Vector-Based RNAi Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Merck & Co. Vector-Based RNAi Products and Services
11.1.5 Merck & Co. Vector-Based RNAi SWOT Analysis
11.1.6 Merck & Co. Recent Developments
11.2 Phio Pharmaceutical
11.2.1 Phio Pharmaceutical Company Information
11.2.2 Phio Pharmaceutical Overview
11.2.3 Phio Pharmaceutical Vector-Based RNAi Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Phio Pharmaceutical Vector-Based RNAi Products and Services
11.2.5 Phio Pharmaceutical Vector-Based RNAi SWOT Analysis
11.2.6 Phio Pharmaceutical Recent Developments
11.3 Quark Pharmaceuticals
11.3.1 Quark Pharmaceuticals Company Information
11.3.2 Quark Pharmaceuticals Overview
11.3.3 Quark Pharmaceuticals Vector-Based RNAi Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Quark Pharmaceuticals Vector-Based RNAi Products and Services
11.3.5 Quark Pharmaceuticals Vector-Based RNAi SWOT Analysis
11.3.6 Quark Pharmaceuticals Recent Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Information
11.4.2 Thermo Fisher Scientific Overview
11.4.3 Thermo Fisher Scientific Vector-Based RNAi Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Thermo Fisher Scientific Vector-Based RNAi Products and Services
11.4.5 Thermo Fisher Scientific Vector-Based RNAi SWOT Analysis
11.4.6 Thermo Fisher Scientific Recent Developments
11.5 Silence Therapeutics
11.5.1 Silence Therapeutics Company Information
11.5.2 Silence Therapeutics Overview
11.5.3 Silence Therapeutics Vector-Based RNAi Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Silence Therapeutics Vector-Based RNAi Products and Services
11.5.5 Silence Therapeutics Vector-Based RNAi SWOT Analysis
11.5.6 Silence Therapeutics Recent Developments
11.6 Qiagen NV
11.6.1 Qiagen NV Company Information
11.6.2 Qiagen NV Overview
11.6.3 Qiagen NV Vector-Based RNAi Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Qiagen NV Vector-Based RNAi Products and Services
11.6.5 Qiagen NV Vector-Based RNAi SWOT Analysis
11.6.6 Qiagen NV Recent Developments
11.7 Ionis Pharmaceutical
11.7.1 Ionis Pharmaceutical Company Information
11.7.2 Ionis Pharmaceutical Overview
11.7.3 Ionis Pharmaceutical Vector-Based RNAi Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Ionis Pharmaceutical Vector-Based RNAi Products and Services
11.7.5 Ionis Pharmaceutical Vector-Based RNAi SWOT Analysis
11.7.6 Ionis Pharmaceutical Recent Developments
11.8 Dicerna Pharmaceuticals
11.8.1 Dicerna Pharmaceuticals Company Information
11.8.2 Dicerna Pharmaceuticals Overview
11.8.3 Dicerna Pharmaceuticals Vector-Based RNAi Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Dicerna Pharmaceuticals Vector-Based RNAi Products and Services
11.8.5 Dicerna Pharmaceuticals Vector-Based RNAi SWOT Analysis
11.8.6 Dicerna Pharmaceuticals Recent Developments
11.9 Arrowhead Pharmaceuticals
11.9.1 Arrowhead Pharmaceuticals Company Information
11.9.2 Arrowhead Pharmaceuticals Overview
11.9.3 Arrowhead Pharmaceuticals Vector-Based RNAi Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 Arrowhead Pharmaceuticals Vector-Based RNAi Products and Services
11.9.5 Arrowhead Pharmaceuticals Vector-Based RNAi SWOT Analysis
11.9.6 Arrowhead Pharmaceuticals Recent Developments
11.10 Arcturus Therapeutics
11.10.1 Arcturus Therapeutics Company Information
11.10.2 Arcturus Therapeutics Overview
11.10.3 Arcturus Therapeutics Vector-Based RNAi Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 Arcturus Therapeutics Vector-Based RNAi Products and Services
11.10.5 Arcturus Therapeutics Vector-Based RNAi SWOT Analysis
11.10.6 Arcturus Therapeutics Recent Developments
11.11 Alnylam Pharmaceuticals
11.11.1 Alnylam Pharmaceuticals Company Information
11.11.2 Alnylam Pharmaceuticals Overview
11.11.3 Alnylam Pharmaceuticals Vector-Based RNAi Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.11.4 Alnylam Pharmaceuticals Vector-Based RNAi Products and Services
11.11.5 Alnylam Pharmaceuticals Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Vector-Based RNAi Value Chain Analysis
12.2 Vector-Based RNAi Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Vector-Based RNAi Production Mode & Process
12.4 Vector-Based RNAi Sales and Marketing
12.4.1 Vector-Based RNAi Sales Channels
12.4.2 Vector-Based RNAi Distributors
12.5 Vector-Based RNAi Customers
13 Market Dynamics
13.1 Vector-Based RNAi Industry Trends
13.2 Vector-Based RNAi Market Drivers
13.3 Vector-Based RNAi Market Challenges
13.4 Vector-Based RNAi Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Vector-Based RNAi Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of siRNA Design
Table 3. Major Manufacturers of siRNA Vectors
Table 4. Major Manufacturers of Custom siRNA Construction
Table 5. Global Vector-Based RNAi Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Vector-Based RNAi Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Vector-Based RNAi Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Vector-Based RNAi Revenue Market Share by Region (2018-2024)
Table 9. Global Vector-Based RNAi Revenue by Region (2024-2034) & (US$ Million)
Table 10. Global Vector-Based RNAi Revenue Market Share by Region (2024-2034)
Table 11. Global Vector-Based RNAi Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Units)
Table 12. Global Vector-Based RNAi Sales by Region (2018-2024) & (K Units)
Table 13. Global Vector-Based RNAi Sales Market Share by Region (2018-2024)
Table 14. Global Vector-Based RNAi Sales by Region (2024-2034) & (K Units)
Table 15. Global Vector-Based RNAi Sales Market Share by Region (2024-2034)
Table 16. Global Vector-Based RNAi Sales Quantity by Manufacturers (2018-2024) & (K Units)
Table 17. Global Vector-Based RNAi Sales Quantity Share by Manufacturers (2018-2024)
Table 18. Global Vector-Based RNAi Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Vector-Based RNAi Revenue Share by Manufacturers (2018-2024)
Table 20. Global Vector-Based RNAi Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Key Players of Vector-Based RNAi, Industry Ranking, 2021 VS 2022
Table 22. Global Vector-Based RNAi Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Vector-Based RNAi by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vector-Based RNAi as of 2022)
Table 24. Global Key Manufacturers of Vector-Based RNAi, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Vector-Based RNAi, Product Offered and Application
Table 26. Global Key Manufacturers of Vector-Based RNAi, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Vector-Based RNAi Sales Quantity by Type (2018-2024) & (K Units)
Table 29. Global Vector-Based RNAi Sales Quantity by Type (2024-2034) & (K Units)
Table 30. Global Vector-Based RNAi Sales Quantity Share by Type (2018-2024)
Table 31. Global Vector-Based RNAi Sales Quantity Share by Type (2024-2034)
Table 32. Global Vector-Based RNAi Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Vector-Based RNAi Revenue by Type (2024-2034) & (US$ Million)
Table 34. Global Vector-Based RNAi Revenue Share by Type (2018-2024)
Table 35. Global Vector-Based RNAi Revenue Share by Type (2024-2034)
Table 36. Vector-Based RNAi Price by Type (2018-2024) & (US$/Unit)
Table 37. Global Vector-Based RNAi Price Forecast by Type (2024-2034) & (US$/Unit)
Table 38. Global Vector-Based RNAi Sales Quantity by Application (2018-2024) & (K Units)
Table 39. Global Vector-Based RNAi Sales Quantity by Application (2024-2034) & (K Units)
Table 40. Global Vector-Based RNAi Sales Quantity Share by Application (2018-2024)
Table 41. Global Vector-Based RNAi Sales Quantity Share by Application (2024-2034)
Table 42. Global Vector-Based RNAi Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Vector-Based RNAi Revenue by Application (2024-2034) & (US$ Million)
Table 44. Global Vector-Based RNAi Revenue Share by Application (2018-2024)
Table 45. Global Vector-Based RNAi Revenue Share by Application (2024-2034)
Table 46. Vector-Based RNAi Price by Application (2018-2024) & (US$/Unit)
Table 47. Global Vector-Based RNAi Price Forecast by Application (2024-2034) & (US$/Unit)
Table 48. North America Vector-Based RNAi Revenue by Company (2018-2024) & (US$ Million)
Table 49. North America Vector-Based RNAi Sales Quantity by Company (2018-2024) & (K Units)
Table 50. North America Vector-Based RNAi Sales Quantity by Type (2018-2024) & (K Units)
Table 51. North America Vector-Based RNAi Sales Quantity by Type (2024-2034) & (K Units)
Table 52. North America Vector-Based RNAi Revenue by Type (2018-2024) & (US$ Million)
Table 53. North America Vector-Based RNAi Revenue by Type (2024-2034) & (US$ Million)
Table 54. North America Vector-Based RNAi Sales Quantity by Application (2018-2024) & (K Units)
Table 55. North America Vector-Based RNAi Sales Quantity by Application (2024-2034) & (K Units)
Table 56. North America Vector-Based RNAi Revenue by Application (2018-2024) & (US$ Million)
Table 57. North America Vector-Based RNAi Revenue by Application (2024-2034) & (US$ Million)
Table 58. North America Vector-Based RNAi Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 59. North America Vector-Based RNAi Revenue by Country (2018-2024) & (US$ Million)
Table 60. North America Vector-Based RNAi Revenue by Country (2024-2034) & (US$ Million)
Table 61. North America Vector-Based RNAi Sales Quantity by Country (2018-2024) & (K Units)
Table 62. North America Vector-Based RNAi Sales Quantity by Country (2024-2034) & (K Units)
Table 63. Europe Vector-Based RNAi Sales Quantity by Company (2018-2024) & (K Units)
Table 64. Europe Vector-Based RNAi Revenue by Company (2018-2024) & (US$ Million)
Table 65. Europe Vector-Based RNAi Sales Quantity by Type (2018-2024) & (K Units)
Table 66. Europe Vector-Based RNAi Sales Quantity by Type (2024-2034) & (K Units)
Table 67. Europe Vector-Based RNAi Revenue by Type (2018-2024) & (US$ Million)
Table 68. Europe Vector-Based RNAi Revenue by Type (2024-2034) & (US$ Million)
Table 69. Europe Vector-Based RNAi Sales Quantity by Application (2018-2024) & (K Units)
Table 70. Europe Vector-Based RNAi Sales Quantity by Application (2024-2034) & (K Units)
Table 71. Europe Vector-Based RNAi Revenue by Application (2018-2024) & (US$ Million)
Table 72. Europe Vector-Based RNAi Revenue by Application (2024-2034) & (US$ Million)
Table 73. Europe Vector-Based RNAi Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 74. Europe Vector-Based RNAi Revenue by Country (2018-2024) & (US$ Million)
Table 75. Europe Vector-Based RNAi Revenue by Country (2024-2034) & (US$ Million)
Table 76. Europe Vector-Based RNAi Sales Quantity by Country (2018-2024) & (K Units)
Table 77. Europe Vector-Based RNAi Sales Quantity by Country (2024-2034) & (K Units)
Table 78. China Vector-Based RNAi Sales Quantity by Company (2018-2024) & (K Units)
Table 79. China Vector-Based RNAi Revenue by Company (2018-2024) & (US$ Million)
Table 80. China Vector-Based RNAi Sales Quantity by Type (2018-2024) & (K Units)
Table 81. China Vector-Based RNAi Sales Quantity by Type (2024-2034) & (K Units)
Table 82. China Vector-Based RNAi Revenue by Type (2018-2024) & (US$ Million)
Table 83. China Vector-Based RNAi Revenue by Type (2024-2034) & (US$ Million)
Table 84. China Vector-Based RNAi Sales Quantity by Application (2018-2024) & (K Units)
Table 85. China Vector-Based RNAi Sales Quantity by Application (2024-2034) & (K Units)
Table 86. China Vector-Based RNAi Revenue by Application (2018-2024) & (US$ Million)
Table 87. China Vector-Based RNAi Revenue by Application (2024-2034) & (US$ Million)
Table 88. APAC Vector-Based RNAi Sales Quantity by Company (2018-2024) & (K Units)
Table 89. APAC Vector-Based RNAi Revenue by Company (2018-2024) & (US$ Million)
Table 90. APAC Vector-Based RNAi Sales Quantity by Type (2018-2024) & (K Units)
Table 91. APAC Vector-Based RNAi Sales Quantity by Type (2024-2034) & (K Units)
Table 92. APAC Vector-Based RNAi Revenue by Type (2018-2024) & (US$ Million)
Table 93. APAC Vector-Based RNAi Revenue by Type (2024-2034) & (US$ Million)
Table 94. APAC Vector-Based RNAi Sales Quantity by Application (2018-2024) & (K Units)
Table 95. APAC Vector-Based RNAi Sales Quantity by Application (2024-2034) & (K Units)
Table 96. APAC Vector-Based RNAi Revenue by Application (2018-2024) & (US$ Million)
Table 97. APAC Vector-Based RNAi Revenue by Application (2024-2034) & (US$ Million)
Table 98. APAC Vector-Based RNAi Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 99. APAC Vector-Based RNAi Revenue by Region (2018-2024) & (US$ Million)
Table 100. APAC Vector-Based RNAi Revenue by Region (2024-2034) & (US$ Million)
Table 101. APAC Vector-Based RNAi Sales Quantity by Region (2018-2024) & (K Units)
Table 102. APAC Vector-Based RNAi Sales Quantity by Region (2024-2034) & (K Units)
Table 103. Middle East, Africa and Latin America Vector-Based RNAi Sales Quantity by Company (2018-2024) & (K Units)
Table 104. Middle East, Africa and Latin America Vector-Based RNAi Revenue by Company (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Vector-Based RNAi Sales Quantity by Type (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Vector-Based RNAi Sales Quantity by Type (2024-2034) & (K Units)
Table 107. Middle East, Africa and Latin America Vector-Based RNAi Revenue by Type (2018-2024) & (US$ Million)
Table 108. Middle East, Africa and Latin America Vector-Based RNAi Revenue by Type (2024-2034) & (US$ Million)
Table 109. Middle East, Africa and Latin America Vector-Based RNAi Sales Quantity by Application (2018-2024) & (K Units)
Table 110. Middle East, Africa and Latin America Vector-Based RNAi Sales Quantity by Application (2024-2034) & (K Units)
Table 111. Middle East, Africa and Latin America Vector-Based RNAi Revenue by Application (2018-2024) & (US$ Million)
Table 112. Middle East, Africa and Latin America Vector-Based RNAi Revenue by Application (2024-2034) & (US$ Million)
Table 113. Middle East, Africa and Latin America Vector-Based RNAi Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 114. Middle East, Africa and Latin America Vector-Based RNAi Revenue by Country (2018-2024) & (US$ Million)
Table 115. Middle East, Africa and Latin America Vector-Based RNAi Revenue by Country (2024-2034) & (US$ Million)
Table 116. Middle East, Africa and Latin America Vector-Based RNAi Sales Quantity by Country (2018-2024) & (K Units)
Table 117. Middle East, Africa and Latin America Vector-Based RNAi Sales Quantity by Country (2024-2034) & (K Units)
Table 118. Merck & Co. Company Information
Table 119. Merck & Co. Description and Overview
Table 120. Merck & Co. Vector-Based RNAi Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 121. Merck & Co. Vector-Based RNAi Product and Services
Table 122. Merck & Co. Vector-Based RNAi SWOT Analysis
Table 123. Merck & Co. Recent Developments
Table 124. Phio Pharmaceutical Company Information
Table 125. Phio Pharmaceutical Description and Overview
Table 126. Phio Pharmaceutical Vector-Based RNAi Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 127. Phio Pharmaceutical Vector-Based RNAi Product and Services
Table 128. Phio Pharmaceutical Vector-Based RNAi SWOT Analysis
Table 129. Phio Pharmaceutical Recent Developments
Table 130. Quark Pharmaceuticals Company Information
Table 131. Quark Pharmaceuticals Description and Overview
Table 132. Quark Pharmaceuticals Vector-Based RNAi Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 133. Quark Pharmaceuticals Vector-Based RNAi Product and Services
Table 134. Quark Pharmaceuticals Vector-Based RNAi SWOT Analysis
Table 135. Quark Pharmaceuticals Recent Developments
Table 136. Thermo Fisher Scientific Company Information
Table 137. Thermo Fisher Scientific Description and Overview
Table 138. Thermo Fisher Scientific Vector-Based RNAi Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 139. Thermo Fisher Scientific Vector-Based RNAi Product and Services
Table 140. Thermo Fisher Scientific Vector-Based RNAi SWOT Analysis
Table 141. Thermo Fisher Scientific Recent Developments
Table 142. Silence Therapeutics Company Information
Table 143. Silence Therapeutics Description and Overview
Table 144. Silence Therapeutics Vector-Based RNAi Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 145. Silence Therapeutics Vector-Based RNAi Product and Services
Table 146. Silence Therapeutics Vector-Based RNAi SWOT Analysis
Table 147. Silence Therapeutics Recent Developments
Table 148. Qiagen NV Company Information
Table 149. Qiagen NV Description and Overview
Table 150. Qiagen NV Vector-Based RNAi Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 151. Qiagen NV Vector-Based RNAi Product and Services
Table 152. Qiagen NV Vector-Based RNAi SWOT Analysis
Table 153. Qiagen NV Recent Developments
Table 154. Ionis Pharmaceutical Company Information
Table 155. Ionis Pharmaceutical Description and Overview
Table 156. Ionis Pharmaceutical Vector-Based RNAi Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 157. Ionis Pharmaceutical Vector-Based RNAi Product and Services
Table 158. Ionis Pharmaceutical Vector-Based RNAi SWOT Analysis
Table 159. Ionis Pharmaceutical Recent Developments
Table 160. Dicerna Pharmaceuticals Company Information
Table 161. Dicerna Pharmaceuticals Description and Overview
Table 162. Dicerna Pharmaceuticals Vector-Based RNAi Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 163. Dicerna Pharmaceuticals Vector-Based RNAi Product and Services
Table 164. Dicerna Pharmaceuticals Vector-Based RNAi SWOT Analysis
Table 165. Dicerna Pharmaceuticals Recent Developments
Table 166. Arrowhead Pharmaceuticals Company Information
Table 167. Arrowhead Pharmaceuticals Description and Overview
Table 168. Arrowhead Pharmaceuticals Vector-Based RNAi Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 169. Arrowhead Pharmaceuticals Vector-Based RNAi Product and Services
Table 170. Arrowhead Pharmaceuticals Vector-Based RNAi SWOT Analysis
Table 171. Arrowhead Pharmaceuticals Recent Developments
Table 172. Arcturus Therapeutics Company Information
Table 173. Arcturus Therapeutics Description and Overview
Table 174. Arcturus Therapeutics Vector-Based RNAi Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 175. Arcturus Therapeutics Vector-Based RNAi Product and Services
Table 176. Arcturus Therapeutics Vector-Based RNAi SWOT Analysis
Table 177. Arcturus Therapeutics Recent Developments
Table 178. Alnylam Pharmaceuticals Company Information
Table 179. Alnylam Pharmaceuticals Description and Overview
Table 180. Alnylam Pharmaceuticals Vector-Based RNAi Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 181. Alnylam Pharmaceuticals Vector-Based RNAi Product and Services
Table 182. Alnylam Pharmaceuticals Recent Developments
Table 183. Key Raw Materials Lists
Table 184. Raw Materials Key Suppliers Lists
Table 185. Vector-Based RNAi Distributors List
Table 186. Vector-Based RNAi Customers List
Table 187. Vector-Based RNAi Market Trends
Table 188. Vector-Based RNAi Market Drivers
Table 189. Vector-Based RNAi Market Challenges
Table 190. Vector-Based RNAi Market Restraints
Table 191. Research Programs/Design for This Report
Table 192. Key Data Information from Secondary Sources
Table 193. Key Data Information from Primary Sources
List of Figures
Figure 1. Vector-Based RNAi Product Picture
Figure 2. Global Vector-Based RNAi Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Vector-Based RNAi Market Share by Type in 2022 & 2034
Figure 4. siRNA Design Product Picture
Figure 5. siRNA Vectors Product Picture
Figure 6. Custom siRNA Construction Product Picture
Figure 7. Global Vector-Based RNAi Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 8. Global Vector-Based RNAi Market Share by Application in 2022 & 2034
Figure 9. Hospitals
Figure 10. Speciality Clinics
Figure 11. Vector-Based RNAi Report Years Considered
Figure 12. Global Vector-Based RNAi Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 13. Global Vector-Based RNAi Revenue 2018-2034 (US$ Million)
Figure 14. Global Vector-Based RNAi Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 15. Global Vector-Based RNAi Sales Quantity 2018-2034 (K Units)
Figure 16. Global Vector-Based RNAi Sales Quantity Market Share by Region (2018-2024)
Figure 17. Global Vector-Based RNAi Sales Quantity Market Share by Region (2024-2034)
Figure 18. North America Vector-Based RNAi Sales Quantity YoY (2018-2034) & (K Units)
Figure 19. North America Vector-Based RNAi Revenue YoY (2018-2034) & (US$ Million)
Figure 20. Europe Vector-Based RNAi Sales Quantity YoY (2018-2034) & (K Units)
Figure 21. Europe Vector-Based RNAi Revenue YoY (2018-2034) & (US$ Million)
Figure 22. China Vector-Based RNAi Sales Quantity YoY (2018-2034) & (K Units)
Figure 23. China Vector-Based RNAi Revenue YoY (2018-2034) & (US$ Million)
Figure 24. APAC Vector-Based RNAi Sales Quantity YoY (2018-2034) & (K Units)
Figure 25. APAC Vector-Based RNAi Revenue YoY (2018-2034) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Vector-Based RNAi Sales Quantity YoY (2018-2034) & (K Units)
Figure 27. Middle East, Africa and Latin America Vector-Based RNAi Revenue YoY (2018-2034) & (US$ Million)
Figure 28. The Top 10 and Top 5 Players Market Share by Vector-Based RNAi Sales Quantity in 2022
Figure 29. The Top 10 and Top 5 Players Market Share by Vector-Based RNAi Revenue in 2022
Figure 30. Vector-Based RNAi Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Vector-Based RNAi Sales Quantity Market Share by Type (2018-2034)
Figure 32. Global Vector-Based RNAi Revenue Market Share by Type (2018-2034)
Figure 33. Global Vector-Based RNAi Sales Quantity Market Share by Application (2018-2034)
Figure 34. Global Vector-Based RNAi Revenue Market Share by Application (2018-2034)
Figure 35. North America Vector-Based RNAi Revenue Market Share by Company in 2022
Figure 36. North America Vector-Based RNAi Sales Quantity Market Share by Company in 2022
Figure 37. North America Vector-Based RNAi Sales Quantity Market Share by Type (2018-2034)
Figure 38. North America Vector-Based RNAi Revenue Market Share by Type (2018-2034)
Figure 39. North America Vector-Based RNAi Sales Quantity Market Share by Application (2018-2034)
Figure 40. North America Vector-Based RNAi Revenue Market Share by Application (2018-2034)
Figure 41. North America Vector-Based RNAi Revenue Share by Country (2018-2034)
Figure 42. North America Vector-Based RNAi Sales Quantity Share by Country (2018-2034)
Figure 43. United States Vector-Based RNAi Revenue (2018-2034) & (US$ Million)
Figure 44. Canada Vector-Based RNAi Revenue (2018-2034) & (US$ Million)
Figure 45. Europe Vector-Based RNAi Sales Quantity Market Share by Company in 2022
Figure 46. Europe Vector-Based RNAi Revenue Market Share by Company in 2022
Figure 47. Europe Vector-Based RNAi Sales Quantity Market Share by Type (2018-2034)
Figure 48. Europe Vector-Based RNAi Revenue Market Share by Type (2018-2034)
Figure 49. Europe Vector-Based RNAi Sales Quantity Market Share by Application (2018-2034)
Figure 50. Europe Vector-Based RNAi Revenue Market Share by Application (2018-2034)
Figure 51. Europe Vector-Based RNAi Revenue Share by Country (2018-2034)
Figure 52. Europe Vector-Based RNAi Sales Quantity Share by Country (2018-2034)
Figure 53. Germany Vector-Based RNAi Revenue (2018-2034) & (US$ Million)
Figure 54. France Vector-Based RNAi Revenue (2018-2034) & (US$ Million)
Figure 55. U.K. Vector-Based RNAi Revenue (2018-2034) & (US$ Million)
Figure 56. Italy Vector-Based RNAi Revenue (2018-2034) & (US$ Million)
Figure 57. Russia Vector-Based RNAi Revenue (2018-2034) & (US$ Million)
Figure 58. China Vector-Based RNAi Sales Quantity Market Share by Company in 2022
Figure 59. China Vector-Based RNAi Revenue Market Share by Company in 2022
Figure 60. China Vector-Based RNAi Sales Quantity Market Share by Type (2018-2034)
Figure 61. China Vector-Based RNAi Revenue Market Share by Type (2018-2034)
Figure 62. China Vector-Based RNAi Sales Quantity Market Share by Application (2018-2034)
Figure 63. China Vector-Based RNAi Revenue Market Share by Application (2018-2034)
Figure 64. APAC Vector-Based RNAi Sales Quantity Market Share by Company in 2022
Figure 65. APAC Vector-Based RNAi Revenue Market Share by Company in 2022
Figure 66. APAC Vector-Based RNAi Sales Quantity Market Share by Type (2018-2034)
Figure 67. APAC Vector-Based RNAi Revenue Market Share by Type (2018-2034)
Figure 68. APAC Vector-Based RNAi Sales Quantity Market Share by Application (2018-2034)
Figure 69. APAC Vector-Based RNAi Revenue Market Share by Application (2018-2034)
Figure 70. APAC Vector-Based RNAi Revenue Share by Region (2018-2034)
Figure 71. APAC Vector-Based RNAi Sales Quantity Share by Region (2018-2034)
Figure 72. Japan Vector-Based RNAi Revenue (2018-2034) & (US$ Million)
Figure 73. South Korea Vector-Based RNAi Revenue (2018-2034) & (US$ Million)
Figure 74. China Taiwan Vector-Based RNAi Revenue (2018-2034) & (US$ Million)
Figure 75. Southeast Asia Vector-Based RNAi Revenue (2018-2034) & (US$ Million)
Figure 76. India Vector-Based RNAi Revenue (2018-2034) & (US$ Million)
Figure 77. Middle East, Africa and Latin America Vector-Based RNAi Sales Quantity Market Share by Company in 2022
Figure 78. Middle East, Africa and Latin America Vector-Based RNAi Revenue Market Share by Company in 2022
Figure 79. Middle East, Africa and Latin America Vector-Based RNAi Sales Quantity Market Share by Type (2018-2034)
Figure 80. Middle East, Africa and Latin America Vector-Based RNAi Revenue Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Vector-Based RNAi Sales Quantity Market Share by Application (2018-2034)
Figure 82. Middle East, Africa and Latin America Vector-Based RNAi Revenue Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Vector-Based RNAi Sales Quantity Share by Country (2018-2034)
Figure 84. Middle East, Africa and Latin America Vector-Based RNAi Revenue Share by Country (2018-2034)
Figure 85. Brazil Vector-Based RNAi Revenue (2018-2034) & (US$ Million)
Figure 86. Mexico Vector-Based RNAi Revenue (2018-2034) & (US$ Million)
Figure 87. Turkey Vector-Based RNAi Revenue (2018-2034) & (US$ Million)
Figure 88. Israel Vector-Based RNAi Revenue (2018-2034) & (US$ Million)
Figure 89. GCC Countries Vector-Based RNAi Revenue (2018-2034) & (US$ Million)
Figure 90. Vector-Based RNAi Value Chain
Figure 91. Vector-Based RNAi Production Process
Figure 92. Channels of Distribution (Direct Vs Distribution)
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed